tiprankstipranks
Company Announcements

InhaleRx Limited Holds General Meeting and Announces Upcoming Webinar

Story Highlights
  • InhaleRx Limited focuses on developing inhaled drug-device products for pain and mental health.
  • The company held a General Meeting and announced a webinar to discuss recent progress.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
InhaleRx Limited Holds General Meeting and Announces Upcoming Webinar

An update from InhaleRx Limited ( (AU:IRX) ) is now available.

InhaleRx Limited held a General Meeting where a sole resolution was voted on, and the company expressed gratitude to its shareholders for their support. The company announced an upcoming Town Hall webinar led by the CEO and Medical Advisor to update on recent developments and clinical progress, highlighting its commitment to advancing its position in the healthcare industry.

More about InhaleRx Limited

InhaleRx Limited is an Australian healthcare company focused on developing innovative inhaled drug-device products targeting unmet medical needs in the pain management and mental health sectors. The company aims to achieve U.S. FDA approval through efficient regulatory pathways and is investigating treatments for Breakthrough Cancer Pain and Panic Disorder, which currently have limited effective options.

YTD Price Performance: -32.50%

Average Trading Volume: 114,607

Technical Sentiment Consensus Rating: Hold

Current Market Cap: A$5.76M

Learn more about IRX stock on TipRanks’ Stock Analysis page.

Questions or Comments about the article? Write to editor@tipranks.com

Questions or Comments about the article? Write to editor@tipranks.com
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App